Cemiplimab (anti-PD-1)
Product Specifications
CAS Number
1801342-60-8
Synonyms
REGN-2810, cemiplimab-rwlc
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Cemiplimab (anti-PD-1) is an intravenous human monoclonal antibody directed against programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands 1 (PD-L1) and 2 (PD-L2) . Cemiplimab blocks T-cell inactivation and enhances the immune system's anti-tumor response.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Yyj4966-50gEcoli 50 µg (E. coli)
Recombinant Mycobacterium Smegmatis MSMEG_2940 Protein (aa 2-251)
Sign In for Pricing
View Details K1619808 1.0 µg DNA
PDE11A sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
LV625973 1.0 µg DNA
HERPUD1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details K4387204 1.0 µg DNA
Vav1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details